Current Neuro-Oncology

Volume 23 Number 1
15 January 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 1, 15 January

Barbagallo GMV, Certo F, Di Gregorio S, Maione M, Garozzo M, Peschillo S, Altieri R.
Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.
Neurosurg Focus. 2021 Jan;50(1):E20∟. doi: 10.3171/2020.10.FOCUS20744∟. PMID: 33386001∟. Observational study. ˍ

Bettag C, Schregel K, Langer P, Thomas C, Behme D, Stadelmann C, Rohde V, Mielke D.
Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
Neurosurg Focus. 2021 Jan;50(1):E3∟. doi: 10.3171/2020.10.FOCUS20560∟. PMID: 33386004∟. Observational study. ˍ

El Beltagy MA, Atteya MME.
Benefits of endoscope-assisted microsurgery in the management of pediatric brain tumors.
Neurosurg Focus. 2021 Jan;50(1):E7∟. doi: 10.3171/2020.10.FOCUS20620∟. PMID: 33386008∟. Observational study. ˍ

Moorman B, Barbour M, Huang MA.
Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
J Pediatr Hematol Oncol. 2021 Jan;43(1):e141-e145∟. doi: 10.1097/MPH.0000000000002017∟. PMID: 33235141∟. Observational study˰ ˍ

Shetty P, Yeole U, Singh V, Moiyadi A.
Navigated ultrasound-based image guidance during resection of gliomas: practical utility in intraoperative decision-making and outcomes.
Neurosurg Focus. 2021 Jan;50(1):E1∟. doi: 10.3171/2020.10.FOCUS20550∟. PMID: 33386014∟. Observational study. ˍ

Bunevicius A, Suleiman M, Patel S, Martínez Álvarez R, Martinez Moreno NE, Liscak R, Hanuska J, Langlois AM, Mathieu D, Mau C, Caldwell C, Tuanquin LC, Zacharia BE, McInerney J, Lee CC, Yang HC, Peterson JL, Trifiletti DM, Ogino A, Kano H, Warnick RE, Saylany A, Buch LY, Lee JYK, Strickland BA, Zada G, Chang EL, Lunsford LD, Sheehan J.
Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
J Neurosurg. 2021 Jan 1;135(3):862-870∟. doi: 10.3171/2020.7.JNS202064∟. PMID: 33385995∟. Observational study. ˍ

Yin J, Ge X, Shi Z, Yu C, Lu C, Wei Y, Zeng A, Wang X, Yan W, Zhang J, You Y.
Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Theranostics. 2021 Jan 1;11(4):1763-1779∟. doi: 10.7150/thno.47057∟. PMID: 33408780∟. Laboratory investigation. ˍ

Nour Y, Pöttgen C, Kebir S, Lazaridis L, Lüdemann L, Guberina M, Gauler T, Scheffler B, Jabbarli R, Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Glas M, Lübcke W, Stuschke M, Guberina N.
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.
J Appl Clin Med Phys. 2021 Jan 3;22(1):242-250∟. doi: 10.1002/acm2.13144∟. PMID: 33389825∟. Interventional study. ˍ

Zhang S, Sun H, Su X, Yang X, Wang W, Wan X, Tan Q, Chen N, Yue Q, Gong Q.
Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O⁶-methylguanine-DNA methyltransferase promoter methylation in patients with gliomas.
J Magn Reson Imaging. 2021 Jan 3∟. doi: 10.1002/jmri.27498∟. PMID: 33393131∟. Observational study. ˍ

Clavreul A, Aubin G, Delion M, Lemée JM, Ter Minassian A, Menei P.
What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
J Neurooncol. 2021 Jan 4;151(2):113-121∟. doi: 10.1007/s11060-020-03666-7∟. PMID: 33394262∟. Laboratory investigation. ˍ

Huynh-Le MP, Tibbs MD, Karunamuni R, Tringale KR, Salans M, Yip A, Connor M, Simon AB, Vitzthum LK, Reyes A, Macari AC, Moiseenko V, McDonald CR, Hattangadi-Gluth JA.
Microstructural injury to corpus callosum and intra-hemispheric white matter tracts correlate with attention and processing speed decline after brain radiation.
Int J Radiat Oncol Biol Phys. 2021 Jan 4∟. doi: 10.1016/j.ijrobp.2020.12.046∟. PMID: 33412257∟. Observational study. ˍ

Zanello M, Roux A, Senova S, Peeters S, Edjlali M, Tauziede-Espariat A, Dezamis E, Parraga E, Zah-Bi G, Harislur M, Oppenheim C, Sauvageon X, Chretien F, Devaux B, Varlet P, Pallud J.
Robot-Assisted Stereotactic Biopsies in 377 Consecutive Adult Patients with Supratentorial Diffuse Gliomas: Diagnostic Yield, Safety, and Postoperative Outcomes.
World Neurosurg. 2021 Jan 4;148:e301-e313∟. doi: 10.1016/j.wneu.2020.12.127∟. PMID: 33412330∟. Observational study. ˍ

Gomes I, Moreno DA, Dos Reis MB, da Silva LS, Leal LF, Gonçalves GM, Pereira CA, Oliveira MA, de Medeiros Matsushita M, Reis RM.
Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide.
J Neurooncol. 2021 Jan 5;151(2):135-144∟. doi: 10.1007/s11060-020-03675-6∟. PMID: 33400009∟. Laboratory investigation. ˍ

Picart T, Meyronet D, Pallud J, Dumot C, Metellus P, Zouaoui S, Berhouma M, Ducray F, Bauchet L, Guyotat J; French Brain Tumor DataBase; Club de Neuro-Oncologie of the Société Française de Neurochirurgie.
Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.
J Cancer Res Clin Oncol. 2021 Jan 5;147(6):1843-1856∟. doi: 10.1007/s00432-020-03474-6∟. PMID: 33399987∟. Observational study. ˍ

Sadad T, Rehman A, Munir A, Saba T, Tariq U, Ayesha N, Abbasi R.
Brain tumor detection and multi-classification using advanced deep learning techniques.
Microsc Res Tech. 2021 Jan 5∟. doi: 10.1002/jemt.23688∟. PMID: 33400339∟. Laboratory investigation. ˍ

Witteler J, Schild SE, Rades D.
Palliative Radiotherapy of Primary Glioblastoma.
In Vivo. 2021 Jan 5, 2021;35(1):483-487∟. doi: 10.21873/invivo.12282∟. PMID: 33402500∟. Observational study. ˍ

Gajjar A, Robinson GW, Smith KS, Lin T, Merchant TE, Chintagumpala M, Mahajan A, Su J, Bouffet E, Bartels U, Schechter T, Hassall T, Robertson T, Nicholls W, Gururangan S, Schroeder K, Sullivan M, Wheeler G, Hansford JR, Kellie SJ, McCowage G, Cohn R, Fisher MJ, Krasin MJ, Stewart CF, Broniscer A, Buchhalter I, Tatevossian RG, Orr BA, Neale G, Klimo P Jr, Boop F, Srinivasan A, Pfister SM, Gilbertson RJ, Onar-Thomas A, Ellison DW, Northcott PA.
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
J Clin Oncol. 2021 Jan 6;39(7):822-835∟. doi: 10.1200/JCO.20.01372∟. PMID: 33405951∟. Interventional study. ˍ

Rahman MH, Rana HK, Peng S, Hu X, Chen C, Quinn JMW, Moni MA.
Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Brief Bioinform. 2021 Jan 6:bbaa365∟. doi: 10.1093/bib/bbaa365∟. PMID: 33406529∟. Laboratory investigation. ˍ

*

Sever ON, Oktay K, Güzel E, Kaya V, Güzel A, Yıldırım M.
Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment.
Indian J Cancer. 2021 Jan 6;58(1):91-95∟. doi: 10.4103/ijc.IJC_758_18? PMID: 33402574∟. Observational study. ˍ

Van Mater D, Gururangan S, Becher O, Campagne O, Leary S, Phillips JJ, Huang J, Lin T, Poussaint TY, Goldman S, Baxter P, Dhall G, Robinson G, DeWire-Schottmiller M, Hwang EI, Stewart CF, Onar-Thomas A, Dunkel IJ, Fouladi M.
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
Pediatr Blood Cancer. 2021 Jan 6;68(4):e28879∟. doi: 10.1002/pbc.28879∟. PMID: 33405376∟. Interventional study. ˍ

Wang J, Zheng X, Zhang J, Xue H, Wang L, Jing R, Chen S, Che F, Heng X, Li G, Xue F.
An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas.
Eur Radiol. 2021 Jan 6;31(4):1785-1794∟. doi: 10.1007/s00330-020-07581-3∟. PMID: 33409797∟. Laboratory investigation. ˍ

Yavuz BB, Kanyilmaz G, Aktan M.
Factors affecting survival in glioblastoma patients below and above 65 years of age: A retrospective observational study.
Indian J Cancer. 2021 Jan 6∟. doi: 10.4103/ijc.IJC_36_19? PMID: 33402568∟. Observational study. ˍ

Habibi Z, Hajizadeh M, Nozarian Z, Safavi M, Monajemzadeh M, Meybodi KT, Nejat F, Vasei M.
Cytomegalovirus DNA in non-glioblastoma multiforme brain tumors of infants.
Childs Nerv Syst. 2021 Jan 7∟. doi: 10.1007/s00381-021-05038-6∟. PMID: 33409619∟. Laboratory investigation. ˍ

Beig Zali S, Alinezhad F, Ranjkesh M, Daghighi MH, Poureisa M.
Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.
Neuroradiol J. 2021 Jan 8:1971400920983678∟. doi: 10.1177/1971400920983678∟. PMID: 33417503∟. Observational study. ˍ

Rades D, Witteler J, Schild SE, Trillenberg P, Bonsanto MM, Leppert J.
A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme.
Anticancer Res. 2021 Jan 8;41(1):379-384∟. doi: 10.21873/anticanres.14786∟. PMID: 33419834∟. Observational study˰ ˍ

Young JS, Gogos AJ, Pereira MP, Morshed RA, Li J, Barkovich MJ, Hervey-Jumper SL, Berger MS.
Effects of ventricular entry on patient outcome during glioblastoma resection.
J Neurosurg. 2021 Jan 8:1-9∟. doi: 10.3171/2020.7.JNS201362∟. PMID: 33418530∟. Observational study˰ ˍ

Farshchian M, Bardhi R, Daveluy S.
Desquamative skin rash associated with temozolomide in a patient with glioblastoma.
Dermatol Ther. 2021 Jan 9:e14771∟. doi: 10.1111/dth.14771∟. PMID: 33421249∟. Case report. ˍ

Kawahara D, Tang X, Lee CK, Nagata Y, Watanabe Y.
Predicting the Local Response of Metastatic Brain Tumor to Gamma Knife Radiosurgery by Radiomics With a Machine Learning Method.
Front Oncol. 2021 Jan 11;10:569461∟. doi: 10.3389/fonc.2020.569461∟. PMID: 33505904∟. Observational study. ˍ

Nakajo K, Uda T, Kawashima T, Terakawa Y, Ishibashi K, Tsuyuguchi N, Tanoue Y, Nagahama A, Uda H, Koh S, Sasaki T, Ohata K, Kanemura Y, Goto T.
Diagnostic performance of 11C-methionine PET in newly diagnosed and untreated glioma based on the revised WHO 2016 classification.
World Neurosurg. 2021 Jan 11;S1878-8750(21)00033-4.ˍ. doi: 10.1016/j.wneu.2021.01.012∟. PMID: 33444827∟. Observational study. ˍ

Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R.
A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets.
Acta Neuropathol Commun. 2021 Jan 11;9(1):14∟. doi: 10.1186/s40478-020-01107-0∟. PMID: 33431066∟. Observational study. ˍ

Bukowinski A, Chang B, Reid JM, Liu X, Minard CG, Trepel JB, Lee MJ, Fox E, Weigel BJ.
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN).
Pediatr Blood Cancer. 2021 Jan 12;68(4):e28892∟. doi: 10.1002/pbc.28892∟. PMID: 33438318∟. Interventional study. ˍ

Katsigiannis S, Grau S, Krischek B, Er K, Pintea B, Goldbrunner R, Stavrinou P.
MGMT-Positive vs MGMT-Negative Patients With Glioblastoma: Identification of Prognostic Factors and Resection Threshold.
Neurosurgery. 2021 Jan 12;88(4):E323-E329∟. doi: 10.1093/neuros/nyaa562∟. PMID: 33432978∟. Observational study. ˍ

Schüller U, Iglauer P, Dorostkar MM, Mawrin C, Herms J, Giese A, Glatzel M, Neumann JE.
Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.
Acta Neuropathol. 2021 Jan 12;141(2):323-325∟. doi: 10.1007/s00401-020-02259-y∟. PMID: 33433639∟. Observational study. ˍ

Chen X, Zhong L, Lin J, Yu J.
A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern.
J Int Med Res. 2021 Jan13;49(1):300060520981266∟. doi: 10.1177/0300060520981266∟. PMID: 33435779∟. Case report. ˍ

Chung DJ, Arif B, Odia Y, Siomin V.
Chemotherapy-induced changes in tumor consistency can allow gross total resection of previously unresectable brainstem pilocytic astrocytoma.
Surg Neurol Int. 2021 Jan 13;12:12∟. doi: 10.25259/SNI_594_2020∟. PMID: 33500827∟. Case report. ˍ

Gromeier M, Brown MC, Zhang G, Lin X, Chen Y, Wei Z, Beaubier N, Yan H, He Y, Desjardins A, Herndon JE 2nd, Varn FS, Verhaak RG, Zhao J, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Lipp ES, Nair SK, Khasraw M, Peters KB, Randazzo D, Sampson JH, McLendon RE, Bigner DD, Ashley DM.
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.
Nat Commun. 2021 Jan 13;12(1):352∟. doi: 10.1038/s41467-020-20469-6∟. PMID: 33441554∟. Laboratory investigation. ˍ

Wang Z, Su G, Dai Z, Meng M, Zhang H, Fan F, Liu Z, Zhang L, Weygant N, He F, Fang N, Zhang L, Cheng Q.
Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation.
Cell Prolif. 2021 Jan 13;54(3):e12988∟. doi: 10.1111/cpr.12988∟. PMID: 33442944∟ Laboratory investigation. ˍ

Zahid A, Johnson DR, Kizilbash SH.
Efficacy of ¹⁷⁷Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma.
Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 13;5(1):236-240∟. doi: 10.1016/j.mayocpiqo.2020.09.015∟. PMID: 33718799∟. Case report. ˍ

Park SA, Han HR, Ahn S, Ryu CH, Jeun SS.
Combination treatment with VPA and MSCs-TRAIL could increase anti-tumor effects against intracranial glioma.
Oncol Rep. 2021 Jan 14;45(3):869-878∟. doi: 10.3892/or.2021.7937∟. PMID: 33469674∟. Laboratory investigation. ˍ

Dikaios N.
Deep learning magnetic resonance spectroscopy fingerprints of brain tumours using quantum mechanically synthesised data.
NMR Biomed. 2021 Jan 14;34(4):e4479∟. doi: 10.1002/nbm.4479∟. PMID: 33448078∟. Laboratory investigation. ˍ

Valente Aguiar P, Carvalho B, Vaz R, Linhares P.
Body mass index as an independent prognostic factor in glioblastoma.
Cancer Causes Control. 2021 Jan 15;32(4):327-336∟. doi: 10.1007/s10552-020-01388-9∟. PMID: 33447892∟. Observational study. ˍ